6533b828fe1ef96bd1287fda

RESEARCH PRODUCT

A New Hyaluronic Acid Derivative Obtained from Atom Transfer Radical Polymerization as a siRNA Vector for CD44 Receptor Tumor Targeting.

F. PalumboA. Bavuso VolpeF. BongiovìG. PitarresiG. Giammona

subject

Materials Chemistry2506 Metals and AlloyssiRNA deliveryGenetic VectorsBioengineeringATRPATRP; CD44; hyaluronic acid; siRNA delivery; tumor targeting; Antigens CD44; Cell Line Tumor; Drug Delivery Systems; Humans; Methacrylates; Neoplasm Proteins; Genetic Vectors; Hyaluronic Acid; Neoplasms; RNA Small Interfering; Biotechnology; Bioengineering; Biomaterials; Polymers and Plastics; Materials Chemistry2506 Metals and AlloysMethacrylateNeoplasm ProteinDrug Delivery SystemsCell Line TumorNeoplasmsHumansCD44Hyaluronic AcidRNA Small InterferingPolymers and Plastictumor targetingBiomaterialAntigens CD44Neoplasm ProteinsHyaluronan ReceptorsNeoplasmMethacrylatesGenetic VectorDrug Delivery SystemHumanBiotechnology

description

Two derivatives of hyaluronic acid (HA) have been synthesized by atom transfer radical polymerization (ATRP), starting from an ethylenediamino HA derivative (HA-EDA) and by using diethylaminoethyl methacrylate (DEAEMA) as a monomer for polymerization. Both samples, indicated as HA-EDA-pDEAEMA a and b, are able to condense siRNA, as determined by gel retardation assay and resulting complexes show a size and a zeta potential value dependent on polymerization number, as determined by dynamic light scattering measurements. In vitro studies performed on HCT 116 cell line, that over express CD44 receptor, demonstrate a receptor mediated uptake of complexes, regardless of their surface charge. New cationic HA derivatives (HA-EDA-pDEAEMA), synthesized by atom transfer radical polymerization (ATRP) are able to complex siRNA and to form self-assembled nanosystems. In vitro studies performed on HCT 116 cell line, which over express CD44 receptor, demonstrate a receptor-mediated uptake of complexes.

10.1002/mabi.201500129https://pubmed.ncbi.nlm.nih.gov/26136372